Annals of Clinical and Translational Neurology (Sep 2024)

Utilizing thalamic deep brain stimulation for an electronic seizure diary in a definite sudden unexpected death in epilepsy case

  • Surya Suresh,
  • Yash Vakilna,
  • Vladimir Vashin,
  • Samden Lhatoo,
  • Sandipan Pati

DOI
https://doi.org/10.1002/acn3.52153
Journal volume & issue
Vol. 11, no. 9
pp. 2520 – 2525

Abstract

Read online

Abstract Objective Sudden unexpected death in epilepsy (SUDEP) is a serious threat to individuals with intractable epilepsies, contributing to premature mortality. Understanding the elusive pathophysiological mechanisms of SUDEP, especially in cases without observable terminal events, remains a crucial area for investigation. This study aimed to shed light on the burden of epileptiform activity preceding SUDEP by utilizing an automated electronic seizure diary derived from a sensing‐enabled thalamic deep brain stimulator (DBS). Methods Herein, we present the case of a 57‐year‐old man afflicted with intractable multifocal epilepsy secondary to cortical dysplasia and encephalomalacia resulting from severe traumatic brain injury. Despite an initial successful resection and subsequent resurgence of seizures necessitating DBS treatment, the patient tragically succumbed to SUDEP. Results In‐depth analysis of the patient's electronic seizure diary, complemented by data from the sensing‐enabled DBS, unveiled a terminal electrographic seizure. Notably, we observed a significant increase in power within specific frequency bands recorded from the thalamus preceding the terminal event. Furthermore, these heightened band power events displayed a discernible temporal clustering pattern, primarily manifesting during specific morning and evening hours. An autopsy conclusively confirmed the diagnosis of definite SUDEP. Interpretation This unique case report underscores the feasibility of harnessing thalamic DBS sensing capabilities to monitor seizure burden and, potentially, to tailor interventions aimed at reducing seizure frequency and associated mortality risks.